RxDoctor Payments Data

Thuy Ryan, DO

Interventional Cardiology · Myrtle Beach, SCNPI 1548622848

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (47.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Philips North America LLC accounts for 77.5% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $39,102 and has fallen 61.8% since, to $14,955 in 2025. Among interventional cardiology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,896in general payments, 2019–2025

Across 143 payments — averaging $397.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$44K
  • Shockwave Medical, Inc$6K
  • Cagent Vascular Inc$3K
  • Angiodynamics, Inc.$2K
  • Medtronic$933
  • Inari Medical, Inc.$531
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$13,32023%
  • Speaking & faculty fees$9,55017%
  • Travel & lodging$26,94547%
  • Food & beverage$6,92712%
  • Education$1540%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,896 in reported general payments places this provider in the 90th percentile of 117 interventional cardiology providers in South Carolina.

See all interventional cardiology providers in South Carolina

Medicare billing

Part B allowed, 2024
$7,848
Medicare patients
27
Services billed
281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$18,546
BrilintaTicagrelor13$10,688
ClopidogrelClopidogrel Bisulfate94$1,412
Atorvastatin Calcium19$279
Rosuvastatin Calcium12$170

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →